Literature DB >> 17509924

Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature.

Shin-ichiro Kubo1, Akira Iwatake, Nobuyuki Ebihara, Akira Murakami, Nobutaka Hattori.   

Abstract

A 61-year-old man with Parkinson's disease (PD) developed sudden-onset visual impairment after initiation of amantadine treatment. Ophthalmologic examination revealed corneal endothelial edema. Discontinuation of amantadine resulted in rapid improvement of visual acuity. A review of the literature indicated only a few reports of amantadine-associated corneal dysfunction in patients with neurological disorders as well as influenza syndrome, but none with PD. Amantadine-associated visual impairment in PD could be possibly overlooked, since PD mainly affects elderly people who often develop aging-related ocular changes. The present report alerts neurologists and physicians in general to the peculiar ophthalmologic side effect of amantadine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509924     DOI: 10.1016/j.parkreldis.2007.03.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  11 in total

1.  Sudden onset of amantadine-induced reversible bilateral corneal edema in an elderly patient: case report and literature review.

Authors:  Atsuhiro Hotehama; Tatsuya Mimura; Tomohiko Usui; Hidetoshi Kawashima; Shiro Amano
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

2.  Bilateral corneal edema associated with amantadine.

Authors:  Yelin Yang; Salina Teja; Kashif Baig
Journal:  CMAJ       Date:  2015-05-19       Impact factor: 8.262

Review 3.  Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia.

Authors:  Santiago Perez-Lloret; Olivier Rascol
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

4.  Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-12

Review 5.  The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Authors:  Klaus Seppi; Daniel Weintraub; Miguel Coelho; Santiago Perez-Lloret; Susan H Fox; Regina Katzenschlager; Eva-Maria Hametner; Werner Poewe; Olivier Rascol; Christopher G Goetz; Cristina Sampaio
Journal:  Mov Disord       Date:  2011-10       Impact factor: 10.338

6.  Amantadine can induce intra-epithelial deposition in the cornea.

Authors:  Asayo Yoshinaka; Taiichiro Chikama; Yoshiaki Kiuchi
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-05

7.  Parkinson's Disease and Its Management: Part 4: Treatment of Motor Complications.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-11

8.  Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-10

9.  The effect of systemic amantadine sulfate on malondialdehyde and total thiol levels in rat corneas.

Authors:  Züleyha Yalniz-Akkaya; Vildan Fidanci; Aytul Kilinc; Ayse Burcu; Guner O Uney; Firdevs Ornek
Journal:  J Ophthalmic Vis Res       Date:  2014 Jul-Sep

10.  Amantadine induced corneal edema in a patient with primary progressive freezing of gait.

Authors:  Young Eun Kim; Ji Young Yun; Hui-Jun Yang; Han-Joon Kim; Mee Kum Kim; Won Ryang Wee; Beom S Jeon
Journal:  J Mov Disord       Date:  2013-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.